The Familial Risk and HLA Susceptibility among Narcolepsy Patients in Hong Kong Chinese
Open Access
- 1 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 30 (7) , 851-858
Abstract
To explore the familial aggregation and HLA susceptibility of narcolepsy in Hong Kong Chinese by objective sleep measurements and HLA typing. Case control design Twelve narcoleptic probands, 34 first-degree relatives, and 30 healthy controls. N/A Each subject underwent a standardized nocturnal polysomnogram (PSG), followed by a daytime multiple sleep latency test (MSLT). HLA typing was performed for all subjects. One relative (2.9%) was diagnosed as suffering from narcolepsy with cataplexy. Nearly 30% of the relatives fulfilled the criteria of narcolepsy spectrum disorder (shortened mean sleep latency [MSL] and/or the presence of sleep onset REM periods [SOREMPs]). When using the population data for comparison, the relative risk of narcolepsy in first-degree relatives was 85.3. The odds ratio of narcolepsy spectrum disorder in first-degree relatives was 5.8 (95% CI: 1.2 – 29.3) when compared to healthy controls. There existed 6 multiplex families, in which all 10 relatives with narcolepsy spectrum disorders, including all 3 relatives with multiple SOREMPs, were positive for HLA DQB1*0602. Our study demonstrated a definitive familial aggregation of narcolepsy, narcolepsy spectrum disorders, and possibly cataplexy in Hong Kong Chinese. This familial aggregation supported an inherited basis for narcolepsy spectrum. The tight co-segregation of HLA DQB1*0602 and narcolepsy spectrum disorders might suggest that HLA typing, especially DQB1*0602, at least partly confer the familial risk of narcolepsy. In addition, our study suggested that the subjective questionnaire measurements including Ullanlinna Narcolepsy Scale and Epworth Sleepiness Scale were unable to detect the presence of narcolepsy spectrum disorders among the relatives. A stringent objective measurement-based design for family studies is suggested for future study. Further studies are indicated for the determination of the mode and molecular level of narcolepsy transmission. Chen L; Fong SYY; Lam CW et al. The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese. SLEEP 2007;30(7):851-858.Keywords
This publication has 32 references indexed in Scilit:
- Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adultsBrain, 2006
- Frequency of narcolepsy symptoms and other sleep disorders in narcoleptic patients and their first‐degree relativesJournal of Sleep Research, 2005
- The prevalence of narcolepsy among Chinese in Hong KongAnnals of Neurology, 2002
- Proposed supplements and amendments to ‘A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects’, the Rechtschaffen & Kales (1968) standardPsychiatry and Clinical Neurosciences, 2001
- HLA DR2 and DQ1 frequency among narcoleptic patients in Hong Kong ChinesePsychiatry and Clinical Neurosciences, 1998
- Narcolepsy in Hong Kong Chinese ‐ a preliminary experienceAustralian and New Zealand Journal of Medicine, 1994
- A patient with coexisting narcolepsy and morbid jealousy showing favourable response to fluoxetine1994
- Familial narcolepsy in FinlandActa Neurologica Scandinavica, 1991
- Narcolepsy and HLA in the JapaneseAnnals of the New York Academy of Sciences, 1988
- A FAMILY STUDY OF 50 REM NARCOLEPTICSActa Neurologica Scandinavica, 1974